BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2882682)

  • 21. [Beta-adrenergic hypertonia in psychosomatic manifestations of anxiety and the therapeutic effect of a cardioselective beta-blockader: betaxolol].
    Le Van D; Mayeux D; Kohler C; Regnier F; Coquelin JP; Grilliat JP
    Therapie; 1988; 43(6):451-6. PubMed ID: 2906488
    [No Abstract]   [Full Text] [Related]  

  • 22. Early postmarketing surveillance of betaxolol hydrochloride, September 1985-September 1986.
    Nelson WL; Kuritsky JN
    Am J Ophthalmol; 1987 Apr; 103(4):592. PubMed ID: 2882681
    [No Abstract]   [Full Text] [Related]  

  • 23. New topical beta-blockers for glaucoma.
    Drug Ther Bull; 1987 Aug; 25(16):63-4. PubMed ID: 2887414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Double-blind study of betaxolol in patients with acute myocardial infarction].
    Yang XS
    Zhonghua Nei Ke Za Zhi; 1985 Dec; 24(12):712-4, 767. PubMed ID: 2869922
    [No Abstract]   [Full Text] [Related]  

  • 25. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
    Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in hemodynamics and renal function during the oral administration of betaxolol].
    Pathe M; Schwartz J
    Therapie; 1985; 40(4):209-12. PubMed ID: 2862715
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of befunolol ophthalmic solution, a beta-adrenergic blocking agent, on ocular hypertension and primary glaucoma].
    Shimizu Y
    Nippon Ganka Gakkai Zasshi; 1982 Dec; 86(12):2123-34. PubMed ID: 6132535
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of befunolol ophthalmic solution, alpha, beta-adrenergic blocking agent, on secondary glaucoma].
    Miki H
    Nippon Ganka Gakkai Zasshi; 1983; 87(1):1-13. PubMed ID: 6133424
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thymoptic in the treatment of glaucoma].
    Koretskaia IuM; Bel'fer IM; Guzeĭ LA; Govorun SI
    Vestn Oftalmol; 1982; (3):11-2. PubMed ID: 6126024
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical effectiveness and mechanism of action of thymoptic in glaucoma].
    Shmyreva VF; Fridman NV; Makashova NV
    Vestn Oftalmol; 1982; (3):8-10. PubMed ID: 6126027
    [No Abstract]   [Full Text] [Related]  

  • 31. [A new beta-blocking agent in the treatment of chronic glaucoma: timolol maleate].
    Demailly P; Lehner MA; Duperré J
    Bull Soc Ophtalmol Fr; 1976; 76(9-10):801-2. PubMed ID: 19158
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term results in the treatment of glaucoma with beta-adrenergic blocking agents.
    Strempel I
    Trans Ophthalmol Soc N Z; 1981; 33():21-3. PubMed ID: 6114590
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of betaxolol on ventricular arrhythmias. Control of efficacy and tolerance by repetitive Holter recordings].
    Fillette F; Lebrun S; Malkawi K
    Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):409-12. PubMed ID: 2862835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].
    Negishi C; Ueda S; Kanai A; Nakajima A; Funahashi M; Kitazawa Y; Komemushi S
    Nippon Ganka Gakkai Zasshi; 1981 Jan; 85(1):57-66. PubMed ID: 6114632
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of betaxolol (Kerlone) as a once-daily treatment for hypertension in 4685 patients.
    Djian J
    Br J Clin Pract; 1985 May; 39(5):188-91. PubMed ID: 2866790
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
    Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
    Brooks AM; Gillies WE
    Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ocular hypotensive effects of befunolol to glaucomatous eyes--comparison with pilocarpine].
    Makiura M; Uyama M; Sasamoto H; Mantani M; Hattori M
    Nippon Ganka Gakkai Zasshi; 1982; 86(6):565-72. PubMed ID: 6127926
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the antihypertensive effects of betaxolol to atenolol.
    Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
    Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.